Targeting NSD2-mediated SRC-3 liquid–liquid phase separation sensitizes bortezomib treatment in multiple myeloma

Development of chemoresistance is the main reason for failure of clinical management of multiple myeloma (MM), but the genetic and epigenetic aberrations that interact to confer such chemoresistance remains unknown. In the present study, we find that high steroid receptor coactivator-3 (SRC-3) expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jing, Xie, Ying, Guo, Jing, Li, Xin, Wang, Jingjing, Jiang, Hongmei, Peng, Ziyi, Wang, Jingya, Wang, Sheng, Li, Qian, Ye, Linquan, Zhong, Yuping, Zhang, Qiguo, Liu, Xiaozhi, Lonard, David M., Wang, Jin, O’Malley, Bert W., Liu, Zhiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884723/
https://www.ncbi.nlm.nih.gov/pubmed/33589584
http://dx.doi.org/10.1038/s41467-021-21386-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884723/
https://www.ncbi.nlm.nih.gov/pubmed/33589584
http://dx.doi.org/10.1038/s41467-021-21386-y

Ejemplares similares